Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Health Catalyst Inc (NASDAQ: HCAT) was $4.60 for the day, up 1.55% from the previous closing price of $4.53. In other words, the price has increased by $1.55 from its previous closing price. On the day, 0.67 million shares were traded. HCAT stock price reached its highest trading level at $4.67 during the session, while it also had its lowest trading level at $4.41.
Ratios:
Our analysis of HCAT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.46.
Evercore ISI Upgraded its In-line to Outperform on January 03, 2024, while the target price for the stock was maintained at $11.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’25 when Landry Benjamin sold 13,827 shares for $4.55 per share. The transaction valued at 62,860 led to the insider holds 160,437 shares of the business.
LeSueur Daniel sold 16,902 shares of HCAT for $76,331 on Mar 05 ’25. The Chief Operating Officer now owns 216,250 shares after completing the transaction at $4.52 per share. On Mar 06 ’25, another insider, BENJAMIN LANDRY, who serves as the Officer of the company, bought 13,827 shares for $4.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 322968768 and an Enterprise Value of 333233984. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.05 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at 1.087 whereas that against EBITDA is -13.138.
Stock Price History:
The Beta on a monthly basis for HCAT is 1.46, which has changed by -0.36813188 over the last 52 weeks, in comparison to a change of 0.08572841 over the same period for the S&P500. Over the past 52 weeks, HCAT has reached a high of $9.24, while it has fallen to a 52-week low of $3.76. The 50-Day Moving Average of the stock is -8.96%, while the 200-Day Moving Average is calculated to be -32.79%.
Shares Statistics:
HCAT traded an average of 827.56K shares per day over the past three months and 628250 shares per day over the past ten days. A total of 70.21M shares are outstanding, with a floating share count of 66.95M. Insiders hold about 4.65% of the company’s shares, while institutions hold 77.20% stake in the company. Shares short for HCAT as of 1741910400 were 2938917 with a Short Ratio of 3.55, compared to 1739491200 on 2063283. Therefore, it implies a Short% of Shares Outstanding of 2938917 and a Short% of Float of 4.2600001999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
